VKTX Viking Therapeutics, Inc.

Fundamentals / CIK 0001607678 / USD

Viking Therapeutics, Inc. reported $0 in revenue and a net loss of $627.2M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VKTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$336.3MFY 2016 Revenue: $0FY 2016 Net Income: -$14.73M2016FY 2017 Revenue: $0FY 2017 Net Income: -$20.58M2017FY 2018 Revenue: $0FY 2018 Net Income: -$22.06M2018FY 2019 Revenue: $0FY 2019 Net Income: -$25.78M2019FY 2020 Revenue: $0FY 2020 Net Income: -$39.49M2020FY 2021 Revenue: $0FY 2021 Net Income: -$54.99M2021FY 2022 Revenue: $0FY 2022 Net Income: -$68.87M2022FY 2023 Revenue: $0FY 2023 Net Income: -$85.89M2023FY 2024 Revenue: $0FY 2024 Net Income: -$110.0M2024FY 2025 Revenue: $0FY 2025 Net Income: -$359.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $345.0M $101.6M $63.81M $54.23M $44.98M $31.93M $23.56M $19.04M $13.74M $9.00M
Total Operating Expenses $393.3M $150.9M $100.8M $70.36M $55.68M $42.66M $32.69M $26.16M $19.07M $13.85M
Operating Income -$393.3M -$150.9M -$100.8M -$70.36M -$55.68M -$42.66M -$32.69M -$26.16M -$19.07M -$13.85M
Income Before Tax -$359.6M -$110.0M -$85.89M -- -- -- -- -- -- --
Income Tax Expense $1.0K $1.0K $1.0K $1.0K $2.0K $0 $0 $0 $0 $0
Net Income -$359.6M -$110.0M -$85.89M -$68.87M -$54.99M -$39.49M -$25.78M -$22.06M -$20.58M -$14.73M
Basic EPS -$3.19 -$1.01 -$0.91 -$0.90 -$0.71 -$0.54 -$0.36 -$0.38 -$0.79 -$0.90
Diluted EPS -$3.19 -$1.01 -$0.91 -$0.90 -$0.71 -$0.54 -$0.36 -$0.38 -$0.79 -$0.90
Basic Shares Outstanding 112.7M 109.0M 94.3M 76.8M 77.2M 72.6M 72.0M 57.6M 26.0M 16.3M
Diluted Shares Outstanding 112.7M 109.0M 94.3M 76.8M 77.2M 72.6M 72.0M 57.6M 26.0M 16.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $166.8M $115.8M $150.2M $153.5M $89.95M $60.15M $41.39M $30.99M
Total Operating Expenses $187.1M $132.6M $164.1M $164.7M $98.56M $74.57M $55.47M $46.24M
Operating Income -$187.1M -$132.6M -$164.1M -$164.7M -$98.56M -$74.57M -$55.47M -$46.24M
Interest Income $4.01M -- -- -- $7.77M -- -- --
Interest Expense $88K -- -- -- $0 -- -- --
Net Income -$183.2M -$128.0M -$158.3M -$157.7M -$90.79M -$65.56M -$45.63M -$35.42M
Basic EPS -$1.55 -$1.10 -$1.37 -- -$0.81 -$0.58 -$0.41 --
Diluted EPS -$1.55 -$1.10 -$1.37 -- -$0.81 -$0.58 -$0.41 --
Basic Shares Outstanding 118.0M 116.3M 115.6M -- 112.3M 112.1M 112.1M --
Diluted Shares Outstanding 118.0M 116.3M 115.6M -- 112.3M 112.1M 112.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $165.8M $26.68M $55.52M $36.63M $26.37M $29.12M $8.38M $24.78M $8.99M $3.08M
Short-Term Investments $539.9M $875.9M $306.6M $118.9M $175.7M $219.3M $267.3M $276.7M $11.59M --
Cash & Short-Term Investments $705.7M $902.6M $362.1M $155.5M $202.1M $248.4M $275.6M $301.5M $20.57M $3.08M
Total Current Assets $715.6M $907.2M $367.2M $167.0M $210.5M $256.1M $283.5M $302.1M $21.85M $13.97M
Total Non-Current Assets $131K $1.10M $1.26M $1.49M $134K $398K $755K $179K $270K $561K
Total Assets $715.7M $908.3M $368.5M $168.5M $210.7M $256.5M $284.3M $302.3M $22.12M $14.54M
Accounts Payable $53.25M $9.81M $7.51M $8.53M $1.44M $3.99M $2.43M $959K $1.53M $1.20M
Total Current Liabilities $76.67M $27.41M $19.14M $21.95M $8.78M $12.13M $6.78M $4.55M $8.66M $6.48M
Total Non-Current Liabilities $0 $630K $936K $1.26M $0 $29K $360K $12K $0 $16K
Total Liabilities $76.67M $28.04M $20.07M $23.21M $8.78M $12.16M $7.14M $4.56M $8.66M $6.49M
Total Debt (incl. Leases) $137K $1.12M $1.26M $1.56M $29K $359K $662K -- -- --
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $358 $208
Retained Earnings -$847.5M -$487.9M -$377.9M -$292.0M -$223.2M -$168.2M -$128.7M -$102.9M -$80.86M -$60.28M
Total Stockholders' Equity $639.1M $880.3M $348.4M $145.3M $201.9M $244.3M $277.1M $297.8M $13.46M $8.04M
Total Equity $639.1M $880.3M $348.4M $145.3M $201.9M $244.3M $277.1M $297.8M $13.46M $8.04M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $677.6M $125.8M $118.1M $165.8M $100.4M $33.88M $37.94M $26.68M
Short-Term Investments $282.2M $375.9M $484.8M $539.9M $614.2M $773.8M $813.9M $875.9M
Cash & Short-Term Investments $959.8M $501.7M $603.0M $705.7M $714.6M $807.7M $851.9M $902.6M
Total Current Assets $973.0M $517.6M $608.2M $715.6M $738.7M $827.0M $866.0M $907.2M
Total Non-Current Assets $4.17M $4.33M $33K $131K $712K $834K $970K $1.10M
Total Assets $977.2M $521.9M $608.2M $715.7M $739.4M $827.9M $867.0M $908.3M
Accounts Payable $82.13M $69.01M $67.18M $53.25M $4.41M $5.49M $7.70M $9.81M
Total Current Liabilities $133.9M $109.7M $106.3M $76.67M $26.07M $31.98M $19.57M $27.41M
Total Non-Current Liabilities $254.7M $3.92M $0 $0 $318K $410K $502K $630K
Total Liabilities $388.6M $113.6M $106.3M $76.67M $26.39M $32.39M $20.07M $28.04M
Total Debt (incl. Leases) $4.04M $4.09M -- $137K $755K $878K $1.00M $1.12M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$1.32B -$1.13B -$1.01B -$847.5M -$689.9M -$599.1M -$533.5M -$487.9M
Total Stockholders' Equity $588.6M $408.3M $501.9M $639.1M $713.0M $795.5M $846.9M $880.3M
Total Equity $588.6M $408.3M $501.9M $639.1M $713.0M $795.5M $846.9M $880.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$359.6M -$110.0M -$85.89M -$68.87M -$54.99M -$39.49M -$25.78M -$22.06M -$20.58M -$14.73M
Stock-Based Compensation $40.82M $29.71M $16.75M $8.67M $6.10M $5.82M $3.74M $2.61M $1.45M $1.79M
Change in Payables $43.44M $2.30M -$1.02M $7.08M -$2.54M $1.55M $1.47M -$508K $264K $677K
Operating Cash Flow -$278.7M -$87.79M -$73.38M -$48.40M -$47.59M -$21.78M -$24.75M -$18.75M -$14.76M -$11.07M
Purchases of Investments -$418.0M -$1.11B -$478.3M -$121.4M -$168.0M -$280.6M -$362.4M -$348.2M -$22.53M -$16.92M
Sales & Maturities of Investments $759.4M $560.0M $299.2M $176.2M $206.0M $322.2M $369.9M $82.47M $20.80M $19.95M
Investing Cash Flow $341.4M -$553.4M -$179.1M $54.75M $37.96M $41.57M $7.46M -$265.7M -$1.73M $3.03M
Common Stock Issued -- -- -- -- -- -- -- $296.6M $22.35M $11.55M
Share Repurchases -- -- -- -$6.79M -- -- -- -- -- -$229
Financing Cash Flow $76.44M $612.5M $271.4M $4.16M $6.88M $950K $887K $300.3M $22.40M $10.35M
Net Change in Cash $139.1M -$28.69M $18.91M $10.52M -$2.75M $20.74M -$16.40M $15.79M $5.91M $2.31M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$183.2M -$128.0M -$158.3M -$157.7M -$90.79M -$65.56M -$45.63M -$35.42M
Stock-Based Compensation $17.89M $11.13M $10.34M $8.59M $7.34M $13.55M $11.35M $5.67M
Change in Payables $13.12M $1.83M $13.93M $48.84M -$1.08M -$2.21M -$2.11M $9.56M
Operating Cash Flow -$138.2M -$125.2M -$114.0M -$85.29M -$94.00M -$47.06M -$52.33M -$31.18M
Purchases of Investments -$12.28M -$70.05M -$72.44M -$40.49M -$21.45M -$123.5M -$232.6M -$137.0M
Sales & Maturities of Investments $104.8M $141.0M $126.6M $116.1M $181.5M $166.0M $295.9M $143.5M
Investing Cash Flow $92.52M $109.4M $54.19M $75.61M $160.0M $42.51M $63.24M $6.58M
Financing Cash Flow $597.6M $23.59M $12.08M $75.10M $480K $507K $349K $1.00M
Net Change in Cash $551.9M $7.84M -$47.71M $65.42M $66.50M -$4.05M $11.26M -$23.60M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -56.3% -12.5% -24.7% -47.4% -27.2% -16.2% -9.3% -7.4% -152.8% -183.2%
Return on Assets (ROA) -50.2% -12.1% -23.3% -40.9% -26.1% -15.4% -9.1% -7.3% -93.0% -101.3%
Current Ratio 9.33x 33.09x 19.19x 7.61x 23.98x 21.12x 41.83x 66.40x 2.52x 2.16x
Quick Ratio 9.21x 32.93x 18.92x 7.08x 23.02x 20.48x 40.67x 66.27x 2.38x 0.47x
Debt to Equity 0.00x 0.00x 0.00x 0.01x 0.00x 0.00x 0.00x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -106.6% -131.0% -94.1% -56.3% -33.3% -21.6% -15.1% -12.5%
Return on Assets (ROA) -64.2% -102.5% -77.7% -50.2% -32.1% -20.7% -14.8% -12.1%
Current Ratio 7.27x 4.72x 5.72x 9.33x 28.34x 25.86x 44.25x 33.09x
Quick Ratio 7.17x 4.57x 5.67x 9.21x 27.41x 25.26x 43.52x 32.93x
Debt to Equity 0.01x 0.01x -- 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001607678) · from March 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal